Dr Reddys receives EIR from USFDA for API facility at Srikakulam

Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) from US FDA, for its API manufacturing plant at Srikakulam, Andhra Pradesh (CTO VI) indicating closure of the audit and the inspection classification of this facility is determined as "Voluntary Action Indicated" (VAI).

It may be noted that the site was issued warning letter in November, 2015 after the inspection in 2014, and was under "Official Action Indicated" classification till now.

With this, all facilities under warning letter are now determined as VAI.

Powered by Capital Market - Live News